|1.||Kuhn, Joachim: 9 articles (11/2009 - 06/2003)|
|2.||Kleesiek, Knut: 9 articles (11/2009 - 06/2003)|
|3.||Götting, Christian: 9 articles (11/2009 - 06/2003)|
|4.||Kuhn, J: 6 articles (07/2013 - 01/2000)|
|5.||Kleesiek, K: 5 articles (06/2007 - 01/2000)|
|6.||Götting, C: 5 articles (06/2007 - 01/2000)|
|7.||Prante, Christian: 4 articles (05/2008 - 05/2005)|
|8.||Schön, Sylvia: 4 articles (12/2006 - 05/2005)|
|9.||Ouzzine, Mohamed: 2 articles (03/2014 - 01/2012)|
|10.||Venkatesan, Narayanan: 2 articles (03/2014 - 01/2012)|
06/26/2003 - "JAR choriocarcinoma cells cultured with 10% fetal calf serum were found to secrete xylosyltransferase with relatively high activities (1.10 mU l(-1)). "
06/26/2003 - "High-density tissue-like cultivation of JAR choriocarcinoma cells for the in vitro production of human xylosyltransferase."
06/26/2003 - "This study clearly demonstrates the successful high-density, tissue-like cultivation of JAR choriocarcinoma cells in a hollow fiber bioreactor resulting in an effective production of native human xylosyltransferase."
02/16/2001 - "First isolation of human UDP-D-xylose: proteoglycan core protein beta-D-xylosyltransferase secreted from cultured JAR choriocarcinoma cells."
08/01/2001 - "Changes in xylosyltransferase activity and in proteoglycan deposition in bleomycin-induced lung injury in rat."
08/01/2001 - "This study examined the catalytic activity of UDP-xylosyltransferase in lung tissue and in isolated fibroblasts, as well as the deposition of the proteoglycans versican, biglycan and decorin in rat lung tissue during bleomycin-induced lung injury. "
|3.||Neoplasm Metastasis (Metastasis)
07/05/2013 - "Here, we consider the suitability of xylosyltransferase-I (XT-I) as a myofibroblast biomarker in skin fibrosis. "
07/05/2013 - "Human xylosyltransferase-I - a new marker for myofibroblast differentiation in skin fibrosis."
12/01/2006 - "Measurement of fibrosis marker xylosyltransferase I activity by HPLC electrospray ionization tandem mass spectrometry."
05/01/2005 - "Serum xylosyltransferase I activity, the new biochemical fibrosis marker, is not affected by renal insufficiency."
08/01/2001 - "The data suggest a participation of myofibroblasts with increased xylosyltransferase activities in accumulation of versican in fibrotic foci of injured lung tissue at the early stages of development of lung fibrosis."
|5.||Systemic Scleroderma (Systemic Sclerosis)
05/01/2005 - "Serum xylosyltransferase I (XT-I) is a marker for the determination of tissue remodeling in systemic sclerosis. "
01/01/2000 - "Elevated serum xylosyltransferase activity correlates with a high level of hyaluronate in patients with systemic sclerosis."
06/01/1999 - "Furthermore, xylosyltransferase activity was correlated with the clinical classification of systemic sclerosis. "
06/01/1999 - "Xylosyltransferase activities in female (mean value 1.28 mU per liter, 90% range 1.10-1.55 mU per liter) and male patients (mean 1.39 mU per liter, 90% range 1.16-1. 57 mU per liter) with systemic sclerosis were significantly increased in comparison with blood donors of a corresponding age. "
06/01/1999 - "Xylosyltransferase activities were determined in serum samples of 30 patients with systemic sclerosis. "
|2.||Uridine Diphosphate (UDP)
|8.||Biological Markers (Surrogate Marker)
|10.||Proteins (Proteins, Gene)